Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Edipol Pharmaceutical Consulting is a small UK-based pharmaceutical consulting company operating through the legal entity Edipol Consulting Limited. The business appears to provide strategic and drug-development consulting services to life sciences companies rather than developing its own therapeutics. Publicly available references indicate that its principal, Dr. Stephen Wooding, has supported start-ups in chief scientific officer and advisory capacities. There is no evidence of an internal clinical pipeline, proprietary platform, or marketed drug portfolio. The company therefore appears best characterized as a specialist life sciences consulting firm serving biotech and pharmaceutical clients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Edipol Pharmaceutical Consulting.